New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ADI;CTRX;DISCA;EQIX;LBTYA;LMCA;REGN;SBAC;VRSK;WDC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 >>
August 19, 2015
09:19 EDTADIOn The Fly: Pre-market Movers
Subscribe for More Information
07:52 EDTADIAnalog Devices growth being driven by Apple, says Jefferies
Subscribe for More Information
06:58 EDTADIAnalog Devices upgraded to Buy from Neutral at SunTrust
Subscribe for More Information
August 18, 2015
18:32 EDTADIOn The Fly: After Hours Movers
Subscribe for More Information
18:30 EDTADIChip makers advance after Analog Devices reports Q3 financial results
Subscribe for More Information
17:10 EDTADIAnalog Devices says consumer revenues grew 'considerably' in Q3
Subscribe for More Information
16:04 EDTADIAnalog Devices sees Q4 adjusted EPS 79c-87c, consensus 79c
Subscribe for More Information
16:02 EDTADIAnalog Devices reports Q3 EPS 77c, consensus 74c
Subscribe for More Information
14:51 EDTADINotable companies reporting after market close
Subscribe for More Information
13:28 EDTADIAnalog Devices technical comments before earnings
Subscribe for More Information
August 17, 2015
20:09 EDTLBTYACable companies test virtual reality offerings, Variety says
Subscribe for More Information
11:34 EDTADIAnalog Devices August volatility elevated into Q3 and outlook
Analog Devices August call option implied volatility is at 68, September is at 27; compared to its 52-week range of 17 to 41 suggesting large price movement into the expected release of Q3 results on Aug 18.
08:06 EDTWDCWestern Digital shares offer attractive entry point, says Jefferies
Jefferies analyst James Kisner believes current share levels provide an attractive entry point into Western Digital. The analyst views consensus earnings expectations as achievable and believes the current valuation does not price in potential upside from MOFCOM approval. He keeps a Buy rating on Western Digital with a $116 price target.
06:22 EDTREGNPiper's Tenthoff sees select biotech names outperforming in second half
Piper Jaffray analyst Edward Tenthoff expects drug launches, clinical data read-outs and potential partnerships to drive outperformance for select biotech names in the second half of 2015. Despite some recent profit-taking, 2015 has been another strong year for biotech stocks, Tenthoff tells investors in a research note. Names with important second half of the year catalysts include Vertex (VRTX), Regeneron (REGN), Seattle Genetics (SGEN), Exelixis (EXEL), Sarepta (SRPT), Novavax (NVAX), Arrowhead (ARWR), Array BioPharma (ARRY), Alnylam (ALNY), Genocea (GNCA), CymaBay (CBAY), Idera Pharmaceuticals (IDRA), Vitae Pharmaceuticals (VTAE).
<< 1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use